MS-282a and MS-282bwere isolated from the culture broth of Streptomyces tauricus ATCC 27470 as inhibitors of smooth muscle myosin light chain kinase (MLCK).MS-282aand MS-282b inhibited the activity of chicken gizzard MLCKwith IC50 values of 3.8 /iM and 5.2 /im, respectively. Cyclic AMP-dependent protein kinase, cyclic GMP-dependent protein kinase and protein kinase C were not inhibited by 150/iM MS-282a at all. It is likely that MS-282a blocks MLCKactivity by antagonizing calmodulin since 1) the compound inhibited calmodulin-dependent but not calmodulinindependent activity of MLCK;2) the inhibition of MLCKwas antagonized by increasing concentrations of calmodulin, and 3) the compound inhibited calmodulin-dependent cyclic nucleotide phosphodiesterase.
Myosin light chain kinase (MLCK)is a regulatory enzyme that participates in smooth muscle contraction1 '2) . It is widely accepted that hormonal and neural signals for contraction induce increases in cytoplasmic Ca2+ concentrations in smooth muscle cells via receptor-mediated pathways. The rise of cytoplasmic Ca2 + is transduced to calmodulin, a ubiquitous Ca2 + binding protein, which activates MLCK to catalyze the transfer of the y-phosphate of ATPto Ser-9 of the 20kDa myosin light chain. Whenthe myosin light chain is phosphorylated, smooth muscle myosin can interact with actin to generate contractile force. Since smooth muscle cells are distributed in arteries and bronchi, inhibitors of MLCK could be therapeutically useful as potential vasodilators and bronchodilators.
During the course of our screening work, we found that Streptomyces tauricus ATCC27470 produced inhibitors of MLCK, designated as MS-282aand MS-282b. In this article, we describe the production, isolation and biological properties of these inhibitors.
Materials and Methods

Fermentation
A 250-ml Erlenmeyer flask containing 50 ml of a seed medium composed of glucose 1 %, soluble starch 1%, peptone 0.5%, yeast extract 0.5%, meat extract 0.3%, KH2PO4 0.1%, MgSO4-7H2O 0.05%, CaCO3 0.2% (pH 7.1 before sterilized) was inoculated with the mycelia of Streptomyces tauricus Gause, Preobrazhenskaya, Sveshnikova, Terekhova and Maximova 19833), KCC-S 0837, ATCC27470 (FERM BP-3716) grown on a Hikey-Tresner agar slant. The inoculated flask was incubated for 3 days at 28°C. A 25 ml portion of the culture was transferred to a 2-liter Erlenmeyer flask containing 300ml of the seed medium, and the flask was incubated for 2 days at 28°C. Six flasks of the second seed culture (total 1.8 liters) were further transferred into a 200-liter tank fermentor containing 100 liters of the seed medium, Present address: Tsukuba Research Laboratories, 2 Miyukigaoka, Tsukuba-shi, Ibaraki 305, Japan and the culture was incubated for 2 days at 28°C with agitation of 150 rpm and aeration of 60 liters/minute. For isolation of MS-282a, the third seed culture was transferred into a 2,000-liter tank fermentor containing 1,000 liters of the following fermentation medium: maltose 4.0%, glucose 0.5%, soluble vegetable protein 4.0%, KH2PO4 0.05%, MgSO4 -7H2O, 0.05%, CaCO3 2.0% (pH 6.5 before sterilization). Fermentation was performed for 7 days at 28°C with agitation of 150rpm and aeration of 400 liters/minute. For the isolation of MS-282b, the second seed culture (1.8 liters) obtained as described above was transferred into a 200-liter tank fermentor containing 100 liters of the following fermentation medium: maltose 4.0%, glucose 0.5%, soybean meal 1.5%, soluble vegetable protein 1.5%, KH2PO40.05%, MgSO4à" 7H20, 0.05%, CaCO32.0% (pH 7.0 before sterilization).
The growth of the microorganism was monitored during fermentation by the measurement of packed cell volume (PCV). Detection of MS-282a and MS-282b in the isolation procedures was carried out on a silica gel TLCplate (Merck, No. 5715) developed with EtOAc-MeOH-conc. NH4OH(88 : 10 : 2) and visualized with I2.
Enzyme Assay
The activity of MLCKwas measured as described previously40. For monitoring the active components during fermentation and isolation, \0 fi\ of culture supernatant or methanol solution of partially purified materials was added to the reaction mixture containing, in a final volume of 0.25 ml, Tris-HCl 25 him (pH 7.5), MgCl2 4mM, CaCl2 0.2mM, calmodulin 2.6nM, peptide substrate 24fiM, MLCK1.5nM, and ATP 400 /zM, and incubated for 30 minutes at 28°C. For precise analysis of the inhibition mechanism of MS-282a, the solution of the inhibitor (5 /il) was preincubated with the reaction mixture without ATPfor 10 minutes at 28°C. The reaction was started by the addition of ATP, and the mixture was incubated for 30 minutes. The reaction was terminated by the addition of 10%of acetic acid, and the reaction mixture was directly analyzed by HPLC as described40. Calmodulin-independent MLCKwas prepared by partial digestion with trypsin as described5). The activity of calmodulin-independentenzymewasmeasuredin the samereaction mixture except that EGTA 0.1 mMwas added instead of CaCl2 and calmodulin. The assay conditions of other enzymes were described previously6).
Materials
MLCK was isolated from chicken gizzard smooth muscle as described6). Calmodulin-dependent cyclic nucleotide phosphodiesterase from bovine brain cortex, CGMP-dependent protein kinase from porcine lung, and protein kinase C from rat brain were prepared as described7 S. tauricus ATCC27470 was cultured for 8 days at 28°C in fermentation media containing maltose 3.0%, glucose 0.5%, MgSO4-7H2O 0.05%, Mg3(PO4)2 *8H2O 0.05% and indicated concentrations of soybean meal, soluble vegetable protein and yeast extract. Active materials were extracted from the mycelia with MeOH, and the inhibition of MLCK activity was measured in the presence of the extracts. monitored during fermentation (Fig. 1) . The active components were produced mainly in mycelia, and the inhibitory activity reached maximumon the 5th day.
The production of the active componentswas greatly affected by the nitrogen source in the fermentation medium. Fermentation was carried out at 30°C for 8 days in 300-ml Erlenmeyer flasks containing the media described in Table 1 . The amount of soluble vegetable protein added in the fermentation mediumwas the most important factor for the production of the active components (Exp.
No. 1, 3~5, Table 1 ). Yeast extract also affected the production of the activity in this experiment (Exp. No. 1 and 7, and 2 and 8). However, the effect of yeast extract was not observed when 4% of soluble vegetable protein was added to the medium(data not shown). Soybean meal showed inhibitory or no effects on the production of the active components (Exp. No. 1 and 2, 5 and 6, and 7 and 8). The crude materials extracted from the mycelia of the microorganism contained active compounds which are structurally similar. It was difficult to separate and isolate all these active compounds because of their similarity in physico-chemical properties. However, we did isolate and purify two components, MS-282a and MS-282b from two fermentation batches. Table 2 . The structures of both compounds (Fig. 4) were determined from their physico-chemical properties and spectral data which will be described in a separate paper8). Biological Activities MS-282a and MS-282b inhibited Ca2+ and calmodulin-dependent activity of chicken gizzard MLCK in concentration-dependent manner (Fig.  5) . The concentrations of needed to inhibit the enzyme activity by 50% (IC50) were 3.8^m and 5.2/xm, respectively ( Table 3) .
Physico-chemical Properties Physico-chemical properties of MS-282a and MS-282b are summarized in
The IC50 values of MS-282a against several enzyme activities are summarized in Table 3 . MS282a had no effect on CAMP-dependent protein kinase, CGMP-dependent protein kinase and protein kinase C at concentrations up to 150//M. The calmodulin-independent activity of MLCK, which was generated by partial tryptic digestion of the enzyme, was inhibited by MS-282a with an IC50 value of 102 fiM. Calmodulin-dependent cyclic nucleotide phosphodiesterase and calmodulin-dependent activity of MLCKwere also inhibited by MS-282a. These data suggest that MS-282a, and probably MS-282b as well, inhibited calmodulin itself or calmodulin-dependent mechanismof the enzymeactivation. In order to AUG. 1994 confirm this hypothesis, we tested whether the inhibitory effect of MS-282aon calmodulin-dependent activity of MLCKcould be overcome by increasing the calmodulin concentration in the assay mixture.
As shown in Fig. 6 , the inhibition curve of MS-282a was shifted towards the right when the calmodulin concentration was increased 20-fold in the MLCK assay mixture.
The antibacterial spectrum of MS-282a is listed in Table 4 . MS-282a inhibited growth of Gram-positive bacteria and C. albicans, but not that of Gram-negative bacteria.
Discussion
We have isolated MS-282a and MS-282b from the culture broth of Streptomyces tauricus ATCC27470, and demonstrated that these compounds are inhibitors of MLCK. The following data suggest that the inhibitory effect of MS-282a on MLCK was achieved by antagonizing calmodulin which binds to the regulatory domain of MLCKto activate this enzyme. 1) The calmodulin-independent activity of MLCK generated by partial tryptic digestion was not inhibited by MS-282a in the concentration range similar to that needed to inhibit calmodulin-dependent activity of MLCK.2) Increased concentrations of calmodulin reduced the potency of MS-282a to inhibit MLCK.This idea is supported by the observations that MS-282a inhibited calmodulin-dependent cyclic nucleotide phosphodiesterase, but not calmodulin-independent protein kinases.
MS-282a and MS-282b are new compounds, the structure of which are close to that of pamamycins produced by Streptomyces alboniger9~11}. It has been reported that pamamycin-607 inhibits growth of Cochliobolus miyabeanus, Diaporthe citri, Bacillus subtilis and Bacillus cereus, and that pamamycin-607 and pamamycin-635Binduce aerial mycelia of an aerial mycelium-less mutant ofS. alboniger1 0' 1^. The antibiotic activity and the aerial mycelium-inducing activity of pamamycins were distinguishable since pamamycin-635A, pamamycin-649A and pamamycin-649B inhibited growth of the mutant of S. alboniger, but did not induce aerial mycelia of the mutant11}. Wehave shown that MS-282ahas an antibacterial spectrum similar to that of pamamycin-607, but we have not tested aerial mycelium-inducing activity of MS-282a. Natsume et al. speculated from the difference in structures of five pamamycins that methyl group, but not ethyl group, at R position (Fig. 4) was important for aerial mycelium-inducing activity of pamamycins11*. It is, therefore, probable from their speculation that MS-282a which has methyl group at R position could induce aerial mycelia of the mutant S. alboniger, but not MS-282bwhich has ethyl group at R position. There are no reports about inhibition of MLCK or other calmodulin-dependent enzymes by pamamycins. Several compounds from various sources have been reported as MLCK inhibitors: ML-9, kaempferol, KT5926, thyroid hormones, wortmannin and MS-347a5'12~16). There are many more diverse structures and sources of calmodulin inhibitors reported (see ref 17 and the references therein). The potency of MS-282a and MS-282b to inhibit MLCKis intermediate compared with that of the other MLCKinhibitors and calmodulin inhibitors in our assay system3). It is believed that despite the structural diversity of known calmodulin inhibitors, their mutual feature is that they contain hydrophobic and often basic groups in their structures; MS-282a and MS-282b share this feature.
